rosiglitazone has been researched along with 6-cyano-7-nitroquinoxaline-2,3-dione in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, KC; Kilgore, MW; Pancani, T; Phelps, JT; Porter, NM; Searcy, JL; Thibault, O | 1 |
1 other study(ies) available for rosiglitazone and 6-cyano-7-nitroquinoxaline-2,3-dione
Article | Year |
---|---|
Distinct modulation of voltage-gated and ligand-gated Ca2+ currents by PPAR-gamma agonists in cultured hippocampal neurons.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Calcium; Calcium Channels; Calcium Signaling; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Embryo, Mammalian; Enzyme-Linked Immunosorbent Assay; Excitatory Amino Acid Antagonists; Female; Hippocampus; Hypoglycemic Agents; Neuroglia; Neurons; Patch-Clamp Techniques; Pioglitazone; PPAR gamma; Pregnancy; Protein Binding; Rats; Receptors, N-Methyl-D-Aspartate; Rosiglitazone; Thiazolidinediones; Time Factors | 2009 |